Author profile

Ashley Essick, MBA, PMP

Clinical Operations Leader & Frontier Enterprise AI Architect

13 years of healthcare and drug development ownership. Contributor to three FDA-approved therapies. Programs delivered across 37 countries and 547+ investigator sites, with $1.95M in margin recovery and $16.8M in audited annual savings across an 18-solution enterprise portfolio.

Focused on making AI governable, inspection-ready, and operationally useful inside regulated (GxP) clinical environments — not as theory, but as delivered systems.

LinkedIn All Publications Credentials & Experience

Credentials

▸MBA — Master of Business Administration
▸PMP — Project Management Professional
▸Kellogg Executive Leadership Certificate — Northwestern University
▸MIT specialized AI training
▸NVIDIA specialized AI training
▸Product Marketing Alliance — Go-to-Market Certification

Affiliations

Areas of expertise

Clinical operations leadershipEnterprise AI strategyAI governance lifecycleGlobal Phase I–III clinical executionFDA regulatory strategyEU AI Act complianceGxP validation and inspection readinessChange management for regulated organizationsGo-to-market strategy for life sciencesPortfolio ROI and financial governance

Published work

Published in PM World Journal • 2026

Ashley Essick, MBA, PMP

Credentials

Affiliations

Areas of expertise

Published work

AI Accountability Is Already Project Management Work

Liability and Accountability Under the EU AI Act

The Drug Got a Supercomputer. The Trial Got a Spreadsheet.

The Real AI Readiness Question Is Not 'What Tool?' Rather It's 'What Decision Are We Improving?'

AI Won't Fix a Broken Protocol. But It Will Expose One Faster.